ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
115.50
-1.48 (-1.27%)
At close: Mar 13, 2026, 4:00 PM EDT
119.76
+4.26 (3.69%)
Pre-market: Mar 16, 2026, 6:25 AM EDT
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 67 employees as of September 30, 2025. The number of employees increased by 5 or 8.06% compared to the same quarter last year.
Employees
67
Change
5
Growth
8.06%
Revenue / Employee
$93,006
Profits / Employee
-$5,140,086
Market Cap
8.99B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 67 | 5 | 8.06% | 67 | 0 |
| Jun 30, 2025 | 69 | 7 | 11.29% | 69 | 0 |
| Mar 31, 2025 | 69 | 8 | 13.11% | 69 | 0 |
| Jun 30, 2024 | 62 | - | - | 62 | 0 |
| Dec 31, 2023 | 61 | 37 | 154.17% | 61 | 0 |
| Dec 31, 2022 | 24 | 0 | - | 24 | 0 |
| Dec 31, 2021 | 24 | -3 | -11.11% | 24 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bio-Techne | 3,100 |
| Exelixis | 1,077 |
| Axsome Therapeutics | 925 |
| Madrigal Pharmaceuticals | 915 |
| Arrowhead Pharmaceuticals | 711 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| Vaxcyte | 507 |
ABVX News
- 3 days ago - Abivax (ABVX) Shares Surge Amid Denial of AstraZeneca Takeover Report - GuruFocus
- 3 days ago - Abivax spokesperson denies takeover rumors reported by French media - Reuters
- 3 days ago - AstraZeneca (AZN) Obtains Exclusive Negotiation Period with Abivax - GuruFocus
- 3 days ago - AstraZeneca (AZN) Engages in Exclusive Takeover Talks with Abivax - GuruFocus
- 3 days ago - AstraZeneca (AZN) Enters Exclusive Agreement Boosting Abivax Shares - GuruFocus
- 4 days ago - Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline - Benzinga
- 4 days ago - Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline - Benzinga
- 4 days ago - Harbor Health Care ETF Q4 2025 Portfolio Review - Seeking Alpha